#1 Remote Patient Monitoring Platform
At Athelas we're bringing simple, life-changing health care products to people around the globe.
The future of healthcare is at the home - we are a team of technologists building the next generation of medical products at the intersection of hardware and software. We won’t stop until we’ve brought the world class tools of a hospital to your home.
We develop hardware & software and diagnostics to improve the lives of chronic care patients (cancer, hypertension, schizophrenia, bipolar disorder).
In the US, 80% of healthcare spend occurs in 20% of patients. We aim to drastically reduce this cost through modern software, hardware, and preventative care services. Its core device (FDA Class 2 cleared) uses machine-learning trained on cell classification to allow chronic patients to monitor their white blood count at home. Its core software product is a platform to help doctors monitor vitals, trends, etc. of such patients, so that physicians and patients can stay aligned without direct interaction.
We've raised $132 million at a $1.5 billion valuation from top tier investors such as General Catalyst, Sequoia Capital, Y Combinator, and Initialized.
Athelas is a Sequoia funded biotech startup working on modern, point-of-care diagnostics using Machine Learning. Our main product is an FDA cleared device for immunoresponse monitoring. We're scaling deployments rapidly across the country, and our customer base includes major pharmaceutical companies. If you're interested in modernizing healthcare and working at the intersection of machine learning and healthcare, we are the right place for you.
Athelas is a small, creative, and hard-working team and we're looking for individuals with a founder-type mentality to join us.